Cardiology Research, ISSN 1923-2829 print, 1923-2837 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Cardiol Res and Elmer Press Inc |
Journal website https://www.cardiologyres.org |
Original Article
Volume 3, Number 4, August 2012, pages 164-171
Depressed Exercise Peak Ejection Rate Detected on Ambulatory Radionuclide Monitoring Reflects End-Stage Cardiac Inotropic Reserve and Predicts Mortality in Ischaemic Cardiomyopathy
Figures
Tables
Patient/age | MI site/LV structural damage | Number of coronary arteries with CAD/ extent of coronary obstructions | ADS extent as % of LV total pixels | ADS rev as % of ADS pixels | New York Heart Association classification | Follow-up results |
---|---|---|---|---|---|---|
*implantable cardioverter-defibrillator (ICD), ** permanent pacemaker implantation for sinus node dysfunction; coronary artery disease (CAD), myocardial infarction (MI), anterior (Ant), inferior (Inf), lateral (Lat), left anterior coronary artery (LAD), left circumflex coronary artery (LCX), right coronary artery (RCA), heart failure (HF). | ||||||
1/62 | Ant | 3/3 by-pass/occluded only graft to LAD | 45 | 9 | 2 | N-SURV (Fatal MI) |
2/62 | Ant/prior LV aneurysm resection | 2/occluded LAD/ LCX with 90% stenosis | 60 | 2 | 3 | N-SURV (HF) |
3/69 | Ant, Inf, Lat | 3/patent stent to RCA and LCX, LAD with 50% stenosis | 49 | 0 | 3 | SURV |
4/76 | Ant, Inf | 1/occluded stent to LAD | 29 | 55 | 3 | SURV |
5/74 | Ant, Inf, Lat /LV aneurysm | 1/occluded LAD | 11 | 0 | 2 | N-SURV (HF) |
6/74 | Ant | 3/3 by-pass with only occluded graft to LAD | 25 | 10 | 3 | N-SURV (HF) |
**7/78 | Ant | 1/LAD with 30% stenosis | 15 | 82 | 2 | SURV |
8/72 | Inf/valvular aortic stenosis | coronary arteries with minimal obstructions | 8 | 0 | 2 | SURV |
9/53 | Ant, Inf, Lat | coronary arteries with minimal obstructions /vasospastic angina | 22 | 0 | 2 | SURV |
10/50 | Inf | ectatic LAD | 7 | 0 | 2 | SURV |
11/62 | Ant, Inf | coronary arteries with minimal obstructions | 20 | 5 | 2 | SURV |
**12/67 | Ant | 3/3 by-pass with only 2 occluded grafts | 28 | 5 | 3 | N-SURV (HF) |
*13/68 | Ant, Lat | 3/severe stenosis not eligible for revascularisation | 47 | 17 | 3 | N-SURV (HF) |
*14/68 | Ant, Lat, Inf | 1/patent stent to RCA | 27 | 0 | 2 | N-SURV |
15/64 | Ant | 1/occluded LAD | 21 | 0 | 2 | SURV |
N-SURV | SURV | N-SURV vs. SURV | ||||||
---|---|---|---|---|---|---|---|---|
rest | P | exercise | rest | P | exercise | rest P | exercise P | |
HR/bpm | 88 ± 11 | 0.2 | 97 ± 17 | 83 ± 12 | 0.001 | 106 ± 10 | 0.4 | 0.2 |
EDV(mL) | 105 ± 5 | 0.2 | 97 ± 16 | 102 ± 5 | 0.7 | 105 ± 22 | 0.2 | 0.4 |
ESV(mL) | 80 ± 8 | 0.02 | 65 ± 20 | 65 ± 11 | 0.02 | 52 ± 16 | 0.008 | 0.2 |
% EF | 25 ± 7 | 0.01 | 34 ± 10 | 38 ± 9 | 0.01 | 50 ± 13 | 0.01 | 0.02 |
PFR(edv/s) | 1.3 ± 0.3 | 0.01 | 1.9 ± 0.6 | 1.3 ± 0.4 | 0.01 | 2.7 ± 0.9 | 0.9 | 0.06 |
PER(edv/s) | 1.4 ± 3 | 0.01 | 2 ± 0.6 | 2.3 ± 0.6 | 0.01 | 3.3 ± 0.7 | 0.003 | 0.003 |